Fidia Advanced Wound Care Solutions

Since 1963, starting from hyaluronic acid and exploiting synergies with regenerative medicine, FIDIA Farmaceutici is at forefront in the development of innovative solutions that allow physicians to customize the best science-based treatments for patients affected by acute and chronic wounds
Fidia’s know-how
Tissue Regeneration Since 1963

More than 55 years of research into HYALURONIC ACID molecule have placed Fidia at the forefront in the production of both natural and functionalized HYALURONIC ACID, using proprietary and validated manufacturing processes, with different ranges of molecular weight, according to the design characteristics of the finished products.

Today, based on its strong experience in the clinical applications of HYALURONIC ACID and in the field of tissue regeneration, Fidia took up the challenge of entering the field of AUTOLOGOUS BIOLOGICAL THERAPY, to bring innovative treatments into the market, thereby allowing physicians to tailor the best treatment to the individual patients.

Discover Fidia
over 50 years of research into Hyaluronic Acid
Italian multinational company, with R&D, manufacturing and sales capabilities, and an extensive product portfolio mainly based on natural and functionalized hyaluronic acid (1,100 patents), in joint care, wound healing, ophthalmology, aesthetics and autologous biological therapy. Manufacturing operations, located in Italy, are inspected and approved by major international health authorities, including the US FDA, and the company extends its global reach through wholly-owned subsidiaries and commercial partners in 100+ countries worldwide.

© Fidia Farmaceutici S.p.A.
Via Ponte della Fabbrica 3/A - 35031 Abano Terme (PD) - Italy
Tel. (+39) 049 8232221 - 2222 Fax (+39) 049 810653
Cap. Soc. € 36.120.000 int. vers. - C.C.I.A.A. PD n. 80793 - Iscr. Reg. Imp. PD
Cod. Fisc. e P. IVA 00204260285

Follow us